Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice

European Neuropsychopharmacology

Volumn 12, Issue 4, 2002, Pages 311-319

  Świa̧der, Mariusz ^a   Borowicz, Kinga K ^a   Porȩbiak, Jacek ^a   Kleinrok, Zdzislaw ^a   Czuczwar, Stanislaw J ^a,b  

^a Medical University   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Ca2+ channel inhibitors; Dantrolene; Drug interaction; Electroshock maximal; LY 300164; Seizure

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; DANTROLENE; FLUNARIZINE; KAINIC ACID RECEPTOR ANTAGONIST; NICARDIPINE; NIFEDIPINE; TALAMPANEL; VOLTAGE GATED CHANNEL FORMING PROTEIN; AMPA RECEPTOR; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; GLAFENINE; GYKI 53405; NICAFENINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CONVULSION; DRUG BLOOD LEVEL; DRUG POTENTIATION; ELECTRIC SHOCK; LONG TERM MEMORY; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTECTION; SEIZURE; SEIZURE THRESHOLD; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; BLOOD; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; PSYCHOMOTOR PERFORMANCE;

ANIMAL; ANTICONVULSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZODIAZEPINES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DANTROLENE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLUNARIZINE; GLAFENINE; MALE; MICE; NIFEDIPINE; PSYCHOMOTOR PERFORMANCE; RECEPTORS, AMPA; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0036019872     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00045-7     Document Type: Article

References (50)

1. Behavioural analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rat
2. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression
3. ++)-permeable AMPA receptors in delayed neurodegeneration
4. Potential antiepileptic drugs. Flunarizine and other calcium entry blockers
5. Open dose-ranging trial of flunarizine as add-on therapy in epilepsy
6. Une nouvelle methode simple pour explorer l'action 'tranquilisante': le test de la cheminee
7. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466 potentiates the anticonvulsant activity of conventional antiepileptics
8. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice
9. Excitatory amino acid receptors in the vertebrate central nervous system
10. Anticonvulsant action of excitatory amino acid antagonists
11. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice
12. Protection against chemically induced seizures by 2-amino-7-phosphoheptanoic acid
13. The new generation of GABA enhancers. Potential in the treatment of epilepsy
14. Influence of the combined treatment of NMDA and non-NMDA receptor antagonists on electroconvulsions in mice
15. Phosphonic analogues of excitatory amino acid raise the threshold for maximal electroconvulsions in mice
16. Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs
17. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice
18. 2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists
19. Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice
20. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs
21. Effects of excitatory amino acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydantoin in mice
22. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice
23. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine
24. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity
25. 2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice
26. 2+ channel inhibitors in mice
27. Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional anti-epileptics against electroconvulsions in mice
28. 2+ channel modulators against experimental seizures in mice
29. Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures
30. Nifedipine for epilepsy? A double-blind, placebo-controlled trial
31. Nimodipine in refractory epilepsy: a placebo-controlled, add-on study
32. A simplified method of evaluating dose-effect experiments
33. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy
34. 2+ release
35. Metabotropic glutamate receptors: synaptic transmission, modulation and plasticity
36. Double-blind, placebo-controlled trial of flunarizine as add-on therapy in epilepsy
37. Seizure-induced cell death produced by repeated tetanic stimulation in vitro: possible role of endoplasmic reticulum calcium stores
38. Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds
39. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurons and area CA1 in hippocampal slices
40. AMPA receptors in epilepsy and as targets for antiepileptic drugs
41. Antiepileptic drugs: pharmacological mechanism and clinical efficacy with consideration of promising developmental stage compounds
42. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k 8644
43. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy
44. Double-blind, cross-over, placebo-controlled study of flunarizine in patients with therapy resistant epilepsy
45. Relief of experimental spasticity and anxiolytic/anticonvulsant action of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline
46. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks
47. Effect of various calcium channel blockers on three different models of limbic seizures in rats
48. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists
49. The competitive NMDA antagonist D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice
50. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice